If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVO.L Regulatory News (DVO)

  • There is currently no data for DVO

Trading Update

29 Apr 2015 07:00

RNS Number : 5817L
Devro PLC
29 April 2015
 



 29 April 2015

 

 

Devro plc

 

 

Trading Update

Devro plc, one of the world's leading manufacturers of collagen products for the food industry, issues the following trading update for the period from 1 January 2015 to date, ahead of its Annual General Meeting to be held at 11.00am today.

Trading has continued in line with the Board's expectations. Total sales volumes have now shown year on year growth for the fourth successive quarter, with strong performances in China, Japan, Germany and North America.

The major investment projects of building new plants in China and the USA continue to progress well, with both the schedule and the budget in line with previous guidance and production due to commence in 2016. The restructuring of Devro's operations in Scotland and Australia has now been completed as planned, and is on track to deliver the expected annual cost reductions of £5 million in 2015.

Operating cash flow continues to be strong, with net debt rising in line with expectations reflecting the planned investment programme.

Currency continues to be a headwind against prior year, but the Board remains confident in the outlook for 2015 which remains unchanged.

ENDS

 

 

For further information, please contact:

 

Devro plc

Peter Page, Chief Executive

Simon Webb, Group Finance Director

 

 

 

Tel No: 020 7182 4960

 

Buchanan

Charles Ryland / Robbie Ceiriog-Hughes

 

 

Tel No: 020 7466 5000

Notes to Editors

 

FTSE listed Devro (the "Group") is one of the world's leading providers of collagen casings to the food industry supplying a wide range of products and technical support to manufacturers of sausages, salamis, hams and other cooked meats. The Group employs 2,200 staff across the world and produces its casings from five manufacturing sites based in Scotland, Australia, the Czech Republic and the USA. Devro reported sales of £232.3 million and profit before tax (before exceptional items) of £26.1 million for the year ended 31 December 2014. Devro is a constituent of the FTSE4Good Index Series which recognises that the company's performance meets globally recognised corporate responsibility standards.

 Further information on Devro can be found on the company's website: www.devro.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSEDFLAFISEIL
Date   Source Headline
4th Mar 20147:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2013
24th Feb 20146:09 pmRNSHolding(s) in Company - Amendment
7th Feb 20143:54 pmRNSHolding(s) in Company
27th Jan 201411:06 amRNSHolding(s) in Company
24th Jan 20141:04 pmRNSHolding(s) in Company
31st Dec 201312:36 pmRNSDirector/PDMR Shareholding
28th Nov 20138:29 amRNSDirector/PDMR Shareholding
25th Nov 20132:13 pmRNSBlocklisting Interim Review
14th Nov 20137:00 amRNSInterim Management Statement
15th Oct 20139:28 amRNSNotification of IMS date and Capital Markets Event
27th Sep 20135:26 pmRNSHolding(s) in Company
12th Sep 20134:46 pmRNSDirector/PDMR Shareholding
30th Aug 201311:29 amRNSTotal Voting Rights
12th Aug 20135:12 pmRNSDirector/PDMR Shareholding
31st Jul 20137:00 amRNS2013 Interim Results
30th Jul 20137:00 amRNSAppointment of Non-Executive Director
22nd Jul 201311:21 amRNSBlocklisting Application
5th Jul 201312:57 pmRNSHolding(s) in Company
2nd Jul 201310:00 amRNSInterim Results Webcast Notification
24th Jun 20137:00 amRNSPre-close trading update
18th Jun 20134:27 pmRNSHolding(s) in Company
14th Jun 20139:30 amRNSNotification of Upcoming Updates
31st May 20135:00 pmRNSTotal Voting Rights
24th May 20135:00 pmRNSBlocklisting Six Monthly Return
13th May 20133:17 pmRNSDirector/PDMR Transaction
3rd May 20133:36 pmRNSDirector/PDMR Transaction
30th Apr 201312:47 pmRNSTotal Voting Rights
23rd Apr 20134:43 pmRNSDirectors Dealings
23rd Apr 20139:24 amRNSHolding(s) in Company
23rd Apr 20137:00 amRNSSite Visit
22nd Apr 201310:34 amRNSHolding(s) in Company
18th Apr 20135:21 pmRNSResults of Annual General Meeting
18th Apr 20137:00 amRNSIMS & AGM
11th Apr 20133:32 pmRNSHolding(s) in Company
5th Apr 20133:10 pmRNSBlocklisting Application
2nd Apr 20138:06 amRNSTotal Voting Rights
28th Mar 20132:43 pmRNSHolding(s) in Company
22nd Mar 20134:35 pmRNSHolding(s) in Company
19th Mar 20134:33 pmRNSDirector/PDMR Shareholding
15th Mar 20132:00 pmRNS2012 Annual Report
14th Mar 20135:10 pmRNSDirector/PDMR Shareholding
1st Mar 20133:48 pmRNSDirector/PDMR Shareholding
26th Feb 201311:44 amRNS2012 Final Dividend Record Date Amendment
26th Feb 20137:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2012
14th Jan 201312:29 pmRNSListing Rule 9.6.14(R) Disclosure
8th Jan 20132:25 pmRNSPreliminary Results Notification
21st Dec 20122:22 pmRNSAnnual Information Update
19th Dec 20125:31 pmRNSDirector/PDMR Shareholding
18th Dec 20128:59 amRNSListing Rule 9.6.14(R) Disclosure
23rd Nov 20128:53 amRNSBlocklisting Six Monthly Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.